- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-MEF2C
MEF2C Polyclonal Antibody for WB, IHC, IF/ICC, FC (Intra), IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (4)
Applications
WB, IHC, IF/ICC, FC (Intra), IP, chIP, ELISA
Conjugaison
Non conjugué
N° de cat : 10056-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules SH-SY5Y, tissu cardiaque de souris, tissu cérébral de souris, tissu de côlon de souris | 
| Résultats positifs en IP | cellules SH-SY5Y | 
| Résultats positifs en IHC | tissu de lymphome humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. | 
| Résultats positifs en IF/ICC | cellules HepG2, | 
| Résultats positifs en FC (Intra) | cellules HeLa, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochimie (IHC) | IHC : 1:20-1:200 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 | 
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 2 publications below | 
| WB | See 31 publications below | 
| IHC | See 11 publications below | 
| IF | See 17 publications below | 
| IP | See 1 publications below | 
| ChIP | See 2 publications below | 
Informations sur le produit
10056-1-AP cible MEF2C dans les applications de WB, IHC, IF/ICC, FC (Intra), IP, chIP, ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris | 
| Réactivité citée | rat, bovin, Chèvre, Humain, porc, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | MEF2C Protéine recombinante Ag0020 | 
| Nom complet | myocyte enhancer factor 2C | 
| Masse moléculaire calculée | 51 kDa | 
| Poids moléculaire observé | 45-70 kDa | 
| Numéro d’acquisition GenBank | BC156603 | 
| Symbole du gène | MEF2C | 
| Identification du gène (NCBI) | 4208 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
MEF2C belongs to the MEF2 family. It is a transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. MEF2C controls cardiac morphogenesis and myogenesis, and is also involved in vascular development[PMID: 20221419]. It plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission[PMID:18599438]. It is crucial for normal neuronal development, distribution, and electrical activity in the neocortex and is necessary for proper development of megakaryocytes and platelets and for bone marrow B lymphopoiesis[PMID: 21666133]. This protein is required for B-cell survival and proliferation in response to BCR stimulation, efficient IgG1 antibody responses to T-cell-dependent antigens and for normal induction of germinal center B cells. It may also be involved in neurogenesis and in the development of cortical architecture. MEF2C exists some isoforms with MV 50-52 kDa, 47 kDa, and 45 kDa, but modified MEF2C is about 55-66 kDa.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for MEF2C antibody 10056-1-AP | Download protocol | 
| IHC protocol for MEF2C antibody 10056-1-AP | Download protocol | 
| IF protocol for MEF2C antibody 10056-1-AP | Download protocol | 
| IP protocol for MEF2C antibody 10056-1-AP | Download protocol | 
| FC protocol for MEF2C antibody 10056-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Nat Biotechnol Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. | ||
| Cell Res Sequential progenitor states mark the generation of pancreatic endocrine lineages in mice and humans. | ||
| Nat Neurosci Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. | ||
| Nat Commun NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. | ||
| Genes Dev Gsx2 controls region-specific activation of neural stem cells and injury-induced neurogenesis in the adult subventricular zone. | 











